We observed higher levels of granulocyte marker: carcinoembryonic antigen‐related cell adhesion molecule (CEACAM) 8, also known as CD66b, in LEVs from the Severe group but not in EVs from other COVID‐19‐positive patients. This evidence concerns the gene CEACAM8 and COVID-19.